← Back to the fund page Use your browser's print dialog and choose “Save as PDF”. A4, two pages.
InvestVerdict

Union Business Cycle Fund

Regular Plan · Growth Option · Sectoral / Thematic · Scheme code 152411

Fund houseUnion Mutual Fund
CategorySectoral / Thematic
Plan & optionRegular · Growth Option
History2.5 years

Returns (%)

 1M3M6M1Y3Y5Y7Y10YLaunch
This scheme 2.665.014.92 9.43 7.59
Nifty 500
benchmark
0.874.312.15 5.2012.4911.41 15.49
Sectoral / Thematic
category median
5.6615.6212.90 13.92

Over a year annualised (CAGR), under a year absolute. Computed from AMFI's published NAV history for this scheme.

Risk

 VolatilitySharpeSortinoBetaAlphaMax fall
This scheme 15.3% 0.07 0.10 0.98 0.03% -20.4% 90.55
Nifty 500
benchmark
17.2%0.35 0.47 -37.3%

Risk-free rate 6.5%. Beta, alpha and R² are regressed on the 29 months this scheme and its benchmark share.

Growth of ₹100 since launch

951041141232026InvestVerdict

Drawdown from peak (%)

0%-7%-15%-22%2026

Every one-year period it has lived through

WindowsWorstMedianBestPeriods that lost money
72 -6.3% 2.5% 17.2% 32%

Every one-year holding period in this scheme's history, not just the last one — the spread a real investor would have met depending only on when they started.

InvestVerdict

Union Business Cycle Fund

Regular Plan · Growth Option

Allocation

By asset

Equity96.71%
Cash & Equivalents3.18%
Debt0.11%

By market cap

Concentration

Number of stocks61
Top 5 stocks23.53%
Top 10 stocks35.40%
Top 20 stocks54.76%
Largest holding8.97%
Largest sectorBanks 24.44%
Effective stocks39.8
Cash3.18%
InvestVerdict

Union Business Cycle Fund

Regular Plan · Growth Option · holdings

Sector split

Banks — 24.4%Pharmaceuticals & Biotechnology — 7.4%Construction — 6.6%IT - Software — 6.2%Finance — 5.1%Chemicals & Petrochemicals — 5.0%Auto Components — 4.9%Healthcare Services — 4.2%Aerospace & Defense — 3.7%Other — 32.5%Banks24.4%Pharmaceuticals & Biotech…7.4%Construction6.6%IT - Software6.2%Finance5.1%Chemicals & Petrochemicals5.0%Auto Components4.9%Healthcare Services4.2%Aerospace & Defense3.7%Other32.5%
Banks24.44%
Pharmaceuticals & Biotechnology7.43%
Construction6.63%
IT - Software6.20%
Finance5.08%
Chemicals & Petrochemicals5.00%
Auto Components4.92%
Healthcare Services4.15%
Aerospace & Defense3.67%
Electrical Equipment3.66%

Not investment advice. InvestVerdict is not a SEBI-registered Investment Adviser or Research Analyst. Every figure is computed from AMFI's published NAV history and the portfolio the AMC filed with AMFI; none of it is a recommendation to buy, hold or sell. Past returns do not predict future ones. Generated 29 Aug 2026.